Ovid Therapeutics logo

Ovid Therapeutics

OVID | NASDAQ
Chart Builder DCF Calculator
$2.40
-$0.14 (-5.51%)
At close: Nov 16, 2026, 4:00 PM ET
$2.44
+$0.04 (+1.60%)
After-hours: Nov 16, 2026, 7:30 PM ET
-5.51%

No price chart data available for 1D timeframe.

Rating

Updated: Nov 16, 2026
52.5
Fundamentals Average
Market Sentiment Bullish
Moat None
Sector Rank #229/1021 (Top 22%)

Key Statistics

Market Data

Market Cap $487.25M
1D Range
2.38 2.66
52W Range
1.22 2.96

Valuation (TTM)

PE -5.85
PB 2.45
EV/EBITDA -8.26

Valuation (NTM)

Forward PE N/A
Forward PEG 0.38
Price Target $6.00
Loading financial charts...

Profile

Ovid Therapeutics Inc. is a biopharmaceutical firm dedicated to creating significant treatments for individuals and families impacted by neurological disorders across the United States. The company's ...

Sector Healthcare
Industry Biotechnology
Employees 23
IPO Date May 5, 2017
Fiscal Year January - December

Latest News

No news articles available yet.

Earnings

Next Earnings
Mar 15, 2027
EPS Est
Pro
Rev Est
Pro
Earnings Details ➞

Analyst Summary

# of Analysts
4
Consensus
Buy
Price Target
$6.00
Upside
+150.00%
Buy (4)
Hold (0)
Sell (0)
Analyst Details ➞

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.